325 related articles for article (PubMed ID: 18597163)
21. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
22. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
23. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
Leng D; Thanki K; Foged C; Yang M
Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
[TBL] [Abstract][Full Text] [Related]
24. Particle size dependence of polymorphism in spray-dried mannitol.
Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
[TBL] [Abstract][Full Text] [Related]
25. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
[TBL] [Abstract][Full Text] [Related]
26. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying.
Ramezani V; Vatanara A; Seyedabadi M; Nabi Meibodi M; Fanaei H
Drug Dev Ind Pharm; 2017 Jul; 43(7):1103-1111. PubMed ID: 28276783
[TBL] [Abstract][Full Text] [Related]
27. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
Bhargava S; Agrawal GP
Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
[TBL] [Abstract][Full Text] [Related]
28. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.
Wang F; Yu W; Popescu C; Ibrahim AA; Yu D; Pearson R; MacKerell AD; Hoag SW
Pharm Dev Technol; 2022 Apr; 27(4):389-398. PubMed ID: 35468028
[TBL] [Abstract][Full Text] [Related]
29. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
[TBL] [Abstract][Full Text] [Related]
30. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
31. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
Cerchiara T; Luppi B; Bigucci F; Zecchi V
Int J Pharm; 2003 Jun; 258(1-2):209-15. PubMed ID: 12753767
[TBL] [Abstract][Full Text] [Related]
32. Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.
Karanje RV; Bhavsar YV; Jahagirdar KH; Bhise KS
AAPS PharmSciTech; 2013 Jun; 14(2):639-48. PubMed ID: 23516110
[TBL] [Abstract][Full Text] [Related]
33. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
34. Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy.
Yang X; Ke W; Zi P; Liu F; Yu L
J Pharm Sci; 2008 Jul; 97(7):2702-19. PubMed ID: 17918724
[TBL] [Abstract][Full Text] [Related]
35. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
[TBL] [Abstract][Full Text] [Related]
36. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
Guo B; Zhong S; Li N; Li X; Yi J; Jin M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
[TBL] [Abstract][Full Text] [Related]
37. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
[TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
Cavalli R; Peira E; Caputo O; Gasco MR
Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
[TBL] [Abstract][Full Text] [Related]
39. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
40. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
